1. Home
  2. RSLS

as 04-18-2025 1:42pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
-
.
-
-
%

Stocks

Health Care

Medical/Dental Instruments

Nasdaq

Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.

Founded: 2002 Country:
United States
United States
Employees: N/A City: SAN CLEMENTE
Market Cap: 3.2M IPO Year: 2007
Target Price: N/A AVG Volume (30 days): 36.0M
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -13.83 EPS Growth: N/A
52 Week Low/High: $0.30 - $29.00 Next Earning Date: 04-04-2025
Revenue: $8,006,000 Revenue Growth: -7.74%
Revenue Growth (this year): 52.8% Revenue Growth (next year): N/A

RSLS Daily Stock ML Predictions

Share on Social Networks: